These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10639162)

  • 21. Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA.
    Singh M; Ott G; Kazzaz J; Ugozzoli M; Briones M; Donnelly J; O'Hagan DT
    Pharm Res; 2001 Oct; 18(10):1476-9. PubMed ID: 11697476
    [No Abstract]   [Full Text] [Related]  

  • 22. Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems.
    Singh M; Kazzaz J; Ugozzoli M; Malyala P; Chesko J; O'Hagan DT
    Curr Drug Deliv; 2006 Jan; 3(1):115-20. PubMed ID: 16472100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines.
    Ott G; Singh M; Kazzaz J; Briones M; Soenawan E; Ugozzoli M; O'Hagan DT
    J Control Release; 2002 Feb; 79(1-3):1-5. PubMed ID: 11853914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly.
    Zhou X; Liu B; Yu X; Zha X; Zhang X; Wang X; Chen Y; Chen Y; Chen Y; Shan Y; Jin Y; Wu Y; Liu J; Kong W; Shen J
    Biomaterials; 2007 Nov; 28(31):4684-92. PubMed ID: 17686512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cationic influenza virosomes as an adjuvanted delivery system for CTL induction by DNA vaccination.
    Jamali A; Holtrop M; de Haan A; Hashemi H; Shenagari M; Memarnejadian A; Roohvand F; Sabahi F; Kheiri MT; Huckriede A
    Immunol Lett; 2012; 148(1):77-82. PubMed ID: 22981929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accell particle-mediated DNA immunization elicits humoral, cytotoxic, and protective immune responses.
    Haynes JR; Fuller DH; Eisenbraun MD; Ford MJ; Pertmer TM
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S43-5. PubMed ID: 7865332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses.
    Hedley ML; Curley J; Urban R
    Nat Med; 1998 Mar; 4(3):365-8. PubMed ID: 9500615
    [No Abstract]   [Full Text] [Related]  

  • 28. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral delivery of microparticles containing plasmid DNA encoding hepatitis-B surface antigen.
    Bhowmik T; D'Souza B; Uddin MN; D'Souza MJ
    J Drug Target; 2012 May; 20(4):364-71. PubMed ID: 22339323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved immunogenicity of biodegradable polymer particles entrapped rotavirus vaccine.
    Nayak B; Ray AR; Panda AK; Ray P
    J Biomater Appl; 2011 Jan; 25(5):469-96. PubMed ID: 20207774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.
    Deml L; Bojak A; Steck S; Graf M; Wild J; Schirmbeck R; Wolf H; Wagner R
    J Virol; 2001 Nov; 75(22):10991-1001. PubMed ID: 11602739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination.
    Castaldello A; Brocca-Cofano E; Voltan R; Triulzi C; Altavilla G; Laus M; Sparnacci K; Ballestri M; Tondelli L; Fortini C; Gavioli R; Ensoli B; Caputo A
    Vaccine; 2006 Jul; 24(29-30):5655-69. PubMed ID: 16781023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
    Saini V; Jain V; Sudheesh MS; Jaganathan KS; Murthy PK; Kohli DV
    Int J Pharm; 2011 Apr; 408(1-2):50-7. PubMed ID: 21291968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C; Peng G; Jin X; Tang J; Chen Z
    Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
    Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates.
    McCluskie MJ; Brazolot Millan CL; Gramzinski RA; Robinson HL; Santoro JC; Fuller JT; Widera G; Haynes JR; Purcell RH; Davis HL
    Mol Med; 1999 May; 5(5):287-300. PubMed ID: 10390545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel antigen-carrier system: the Mycobacterium tuberculosis Acr protein carried by raw starch microparticles.
    Moreno-Mendieta SA; Guillén D; Espitia C; Hernández-Pando R; Sanchez S; Rodríguez-Sanoja R
    Int J Pharm; 2014 Oct; 474(1-2):241-8. PubMed ID: 25093695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive vaccines.
    Chua BY; Al Kobaisi M; Zeng W; Mainwaring D; Jackson DC
    Mol Pharm; 2012 Jan; 9(1):81-90. PubMed ID: 22149016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.